Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Far Eastern New Century (FENC) is a global leader in polyester manufacturing and advanced polymer products. The company has pioneered sustainable textile innovations such as recycled PET bottles and eco-friendly yarns used in sportswear for major international events. FENC’s business spans petrochemicals, textiles, property development, retail, telecoms, banking/finance and more. It has received numerous awards for sustainability and corporate governance[4][7][9].
In response to the COVID‑19 pandemic, FENC developed raw materials for medical-grade face masks supplied globally[4]. The company continues to invest heavily in circular economy technologies.
There are no clinical results or drug development programs; the company does not operate in pharmaceuticals or biotech drug discovery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Far Eastern New Century.